Zhifeng Wei

3.7k total citations
131 papers, 3.0k citations indexed

About

Zhifeng Wei is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Zhifeng Wei has authored 131 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Molecular Biology, 30 papers in Immunology and 25 papers in Cancer Research. Recurrent topics in Zhifeng Wei's work include Immune Response and Inflammation (12 papers), Immune cells in cancer (9 papers) and Pharmacological Effects of Natural Compounds (8 papers). Zhifeng Wei is often cited by papers focused on Immune Response and Inflammation (12 papers), Immune cells in cancer (9 papers) and Pharmacological Effects of Natural Compounds (8 papers). Zhifeng Wei collaborates with scholars based in China, United States and France. Zhifeng Wei's co-authors include Yue Dai, Yufeng Xia, Qi Lv, Simiao Qiao, Yumeng Miao, Bei Tong, Yannong Dou, Mengfan Yue, Ling Yang and Zhengtao Wang and has published in prestigious journals such as Cell, Angewandte Chemie International Edition and SHILAP Revista de lepidopterología.

In The Last Decade

Zhifeng Wei

122 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zhifeng Wei China	33	1.5k	506	483	376	342	131	3.0k
Rajarajan A. Thandavarayan United States	38	1.7k 1.2×	492 1.0×	203 0.4×	293 0.8×	287 0.8×	136	4.2k
Tao Su China	35	1.7k 1.2×	359 0.7×	236 0.5×	441 1.2×	476 1.4×	125	3.6k
Soo‐Jin Jeong South Korea	37	1.8k 1.2×	510 1.0×	458 0.9×	470 1.3×	458 1.3×	147	3.6k
Tao Wen China	30	2.2k 1.5×	647 1.3×	332 0.7×	542 1.4×	153 0.4×	114	3.8k
Dong‐Yun Ouyang China	33	1.9k 1.3×	692 1.4×	260 0.5×	218 0.6×	175 0.5×	82	2.8k
Yan Yang China	31	1.2k 0.8×	287 0.6×	280 0.6×	335 0.9×	170 0.5×	96	2.4k
Xianglu Rong China	27	1.5k 1.0×	690 1.4×	438 0.9×	188 0.5×	284 0.8×	76	3.2k
Hongzhong Li China	32	1.4k 1.0×	445 0.9×	209 0.4×	535 1.4×	260 0.8×	60	2.9k
Guang Liang China	40	2.3k 1.5×	593 1.2×	301 0.6×	529 1.4×	420 1.2×	129	4.7k

Countries citing papers authored by Zhifeng Wei

Since Specialization

Citations

This map shows the geographic impact of Zhifeng Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhifeng Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhifeng Wei more than expected).

Fields of papers citing papers by Zhifeng Wei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhifeng Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhifeng Wei. The network helps show where Zhifeng Wei may publish in the future.

Co-authorship network of co-authors of Zhifeng Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Zhifeng Wei. A scholar is included among the top collaborators of Zhifeng Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhifeng Wei. Zhifeng Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jiang, Chunhong, Jia Wang, Xiaoqian Wu, et al.. (2025). Andrographolide sulfonate alleviates rheumatoid arthritis by inhibiting glycolysis-mediated activation of PI3K/AKT to restrain Th17 cell differentiation. Chinese Journal of Natural Medicines. 23(4). 480–491. 2 indexed citations

Li, Shijia, et al.. (2025). Aryl hydrocarbon receptor impairs HK2-controlled flux of the hexosamine biosynthesis pathway to suppress NETosis in an N-glycosylation-dependent manner. Journal of Advanced Research. 82. 1069–1082. 1 indexed citations

Zhang, Liefeng, Yurui Zhang, Hong Lu, et al.. (2025). Ecliptasaponin II alleviates the radiation enteritis by activating PPARγ to inhibit the apoptosis of endothelial cells. International Immunopharmacology. 161. 115080–115080. 1 indexed citations

Zhu, Yanrong, Jing Zhang, Ming Zhao, et al.. (2024). Facilitation of mucosal healing by estrogen receptor β in ulcerative colitis through suppression of branched-chain amino acid transport and subsequent triggering of autophagy in colonic epithelial cells. Acta Pharmaceutica Sinica B. 15(1). 168–187. 5 indexed citations

Zhang, Jing, et al.. (2024). Bergenin attenuates triptolide-caused premature ovarian failure in mice based on the antioxidant activity. Reproductive Toxicology. 126. 108608–108608. 8 indexed citations

Xiao, Zhenyu, Lina Cui, Nannan He, et al.. (2024). 3D reconstruction of a gastrulating human embryo. Cell. 187(11). 2855–2874.e19. 34 indexed citations

Zhang, X. Y., et al.. (2024). Homoplantaginin alleviates high glucose‐induced vascular endothelial senescence by inhibiting mtDNA–cGAS–STING pathway via blunting DRP1– mitochondrial fission –VDAC1 axis. The FASEB Journal. 38(20). e70127–e70127. 6 indexed citations

Wu, Xiaoqian, et al.. (2024). Aryl Hydrocarbon Receptor Activation Limits the Fatty Acid Synthesis and Subsequent “miR-193a-3p-HDAC3-FASN” Signals to Alleviate Intestinal Fibrosis. Journal of Agricultural and Food Chemistry. 72(23). 13069–13082. 1 indexed citations

Bai, Yujie, et al.. (2024). Silibinin, a commonly used therapeutic agent for non‐alcohol fatty liver disease, functions through upregulating intestinal expression of fibroblast growth factor 15/19. British Journal of Pharmacology. 181(19). 3663–3684. 4 indexed citations

10.

Qiao, Simiao, et al.. (2024). ADORA3 activation promotes goblet cell differentiation via enhancing HMGCS2-mediated ketogenesis in ulcerative colitis. International Immunopharmacology. 140. 112729–112729. 4 indexed citations

11.

Yan, Wenxin, et al.. (2023). 3, 3'-diindolylmethane, a natural aryl hydrocarbon receptor agonist, alleviates ulcerative colitis by enhancing “glycolysis-lactate-STAT3″ and TIP60 signals-mediated Treg differentiation. Molecular Immunology. 163. 147–162. 8 indexed citations

12.

Yang, Ling, Chen Zheng, Yufeng Xia, Yue Dai, & Zhifeng Wei. (2023). 3, 3’-diindolylmethane enhances macrophage efferocytosis and subsequently relieves visceral pain via the AhR/Nrf2/Arg-1-mediated arginine metabolism pathway. Phytomedicine. 116. 154874–154874. 11 indexed citations

13.

Zhu, Yanrong, et al.. (2023). AhR activation promotes Treg cell generation by enhancing Lkb1‐mediated fatty acid oxidation via the Skp2/K63‐ubiquitination pathway. Immunology. 169(4). 412–430. 17 indexed citations

14.

Wang, Jinghua, et al.. (2018). Activation of the mammalian target of rapamycin signaling pathway underlies a novel inhibitory role of ring finger protein 182 in ventricular remodeling after myocardial ischemia‐reperfusion injury. Journal of Cellular Biochemistry. 120(5). 7635–7648. 6 indexed citations

15.

Lv, Qi, Kai Wang, Simiao Qiao, et al.. (2018). Norisoboldine, a natural AhR agonist, promotes Treg differentiation and attenuates colitis via targeting glycolysis and subsequent NAD+/SIRT1/SUV39H1/H3K9me3 signaling pathway. Cell Death and Disease. 9(3). 258–258. 89 indexed citations

16.

Yang, Yan, Xin Wu, Zhifeng Wei, et al.. (2015). Oral curcumin has anti-arthritic efficacy through somatostatin generation via cAMP/PKA and Ca 2+ /CaMKII signaling pathways in the small intestine. Pharmacological Research. 95-96. 71–81. 43 indexed citations

17.

Lv, Qi, Xianyang Zhu, Yufeng Xia, Yue Dai, & Zhifeng Wei. (2015). Tetrandrine inhibits migration and invasion of rheumatoid arthritis fibroblast-like synoviocytes through down-regulating the expressions of Rac1, Cdc42, and RhoA GTPases and activation of the PI3K/Akt and JNK signaling pathways. Chinese Journal of Natural Medicines. 13(11). 831–841. 43 indexed citations

18.

Wei, Zhifeng, Bei Tong, Yufeng Xia, et al.. (2013). Norisoboldine Suppresses Osteoclast Differentiation through Preventing the Accumulation of TRAF6-TAK1 Complexes and Activation of MAPKs/NF-κB/c-Fos/NFATc1 Pathways. PLoS ONE. 8(3). e59171–e59171. 61 indexed citations

19.

Yao, Xiujuan, Yufeng Xia, Zhifeng Wei, et al.. (2012). Puerarin exerts antipyretic effect on lipopolysaccharide-induced fever in rats involving inhibition of pyrogen production from macrophages. Journal of Ethnopharmacology. 141(1). 322–330. 44 indexed citations

20.

Wei, Zhifeng. (2010). Study on microRNAs in urothelial carcinoma(IIgrade) of the bladder. Yixue yanjiusheng xuebao. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact